Masimo (NASDAQ:MASI) Sees Unusually-High Trading Volume – What’s Next?

Shares of Masimo Corporation (NASDAQ:MASI) saw unusually-high trading volume on Tuesday . Approximately 2,009,264 shares were traded during trading, an increase of 24% from the previous session’s volume of 1,614,900 shares.The stock last traded at $175.5250 and had previously closed at $175.40.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a research note on Tuesday, February 17th. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Finally, Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a research report on Tuesday, February 17th. One research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $181.17.

Masimo Trading Up 0.1%

The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47. The stock has a 50-day moving average price of $154.19 and a two-hundred day moving average price of $146.61. The stock has a market cap of $9.46 billion, a PE ratio of -16.70, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21.

Hedge Funds Weigh In On Masimo

Institutional investors have recently added to or reduced their stakes in the company. Corient Private Wealth LLC boosted its position in shares of Masimo by 1.2% during the 4th quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock valued at $44,250,000 after acquiring an additional 4,015 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Masimo during the fourth quarter valued at $116,000. Pacer Advisors Inc. raised its stake in Masimo by 21.1% during the fourth quarter. Pacer Advisors Inc. now owns 7,360 shares of the medical equipment provider’s stock valued at $957,000 after purchasing an additional 1,280 shares in the last quarter. Virtu Financial LLC bought a new position in Masimo during the fourth quarter valued at $258,000. Finally, T. Rowe Price Investment Management Inc. lifted its position in Masimo by 9.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after purchasing an additional 203,395 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.